1. Do selective cyclo-oxygenase-2 nonsteroidal anti-inflammatory agents increase the risk for acute myocardial infarction?

   • Joseph S. Alpert

   Editor’s Commentary Pages: 415 - 416

2. Web alert

   News Pages: 417 - 418

3. Literature alert

   Abstract Pages: 419 - 423

4. Trials in isolated systolic hypertension: An update

   • Bernard Waeber

   OriginalPaper Pages: 427 - 434

5. Hypertension and dementia

   • Olivier Hanon
   • Marie Laure Seux
   • Françoise Forette

   OriginalPaper Pages: 435 - 440

6. The J-curve in hypertension

   • John Cruickshank

   OriginalPaper Pages: 441 - 452

7. Leptin: Sympathetic and cardiovascular effects

   • Robert J. Richards
   • Anthony Blalock
   • Efrain Reisin

   OriginalPaper Pages: 453 - 458

8. Clinical trials report

   • Peter W. F. Wilson

   BriefCommunication Pages: 461 - 462

9. Newer pharmaceutical agents to treat lipid disorders

   • Michael H. Davidson

   OriginalPaper Pages: 463 - 469

10. Niacin, lipids, and heart disease

    • Shaista Malik
    • Moti L. Kashyap

    OriginalPaper Pages: 470 - 476

11. Estrogen therapies, lipids, and the heart disease prevention controversy

    • Robert H. Knopp
    • Keiko Aikawa
    • Eleanor A. Knopp

    OriginalPaper Pages: 477 - 482

12. Plasma lipoprotein concentrations in ethnic populations

    • Karol E. Watson

    OriginalPaper Pages: 483 - 487

13. Physical activity and its effects on lipids

    • Philippe O. Szapary
    • LeAnne T. Bloedon
    • Gary D. Foster

    OriginalPaper Pages: 488 - 493